Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-11-10 Sale | 2022-11-14 9:00 pm | Zymeworks BC Inc. | ZYME | Josephson Neil Chief Medical Officer | 2,475 | $8.099 | $20,045 | 26,221 (Direct) | View |
| 2022-03-10 Sale | 2022-03-11 9:00 pm | Zymeworks Inc. | ZYME | Klompas Neil A Chief Operating Officer | 2,979 | $6.88 | $20,496 | 221,893 (Indirect Direct) | View |
| 2022-01-07 Purchase | 2022-01-11 9:47 pm | Zymeworks Inc. | ZYME | Josephson Neil Chief Medical Officer | 5,000 | $14.28 | $71,386 | 7,119 (Direct) | View |
| 2021-07-15 Sale | 2021-07-16 9:30 pm | Zymeworks Inc. | ZYME | Tehrani Ali Chief Executive Officer | 44,991 | $36 | $1,619,676 | 357,027 (Indirect Direct) | View |
| 2021-07-12 Sale | 2021-07-13 8:00 pm | Zymeworks Inc. | ZYME | Tehrani Ali Chief Executive Officer | 12,669 | $36.12 | $457,635 | 360,827 (Indirect Direct) | View |
| 2021-04-13 Sale | 2021-04-13 9:30 pm | Zymeworks Inc. | ZYME | Priour James Chief Commercial Officer | 950 | $27.93 | $26,533 | 6,537 (Direct) | View |
| 2021-03-15 Sale | 2021-03-17 8:00 pm | Zymeworks Inc. | ZYME | O'Driscoll Kathryn Chief People Officer | 786 | $34.72 | $27,290 | 100,000 (Direct) | View |
| 2021-03-10 Sale | 2021-03-12 8:00 pm | Zymeworks Inc. | ZYME | O'Driscoll Kathryn Chief People Officer | 568 | $34.95 | $19,854 | 43,498 (Direct) | View |
| 2021-03-10 Sale | 2021-03-12 8:00 pm | Zymeworks Inc. | ZYME | Polverino Anthony J. Chief Scientific Officer | 1,048 | $34.95 | $36,631 | 92,854 (Direct) | View |
| 2021-03-10 Sale | 2021-03-12 8:00 pm | Zymeworks Inc. | ZYME | Tehrani Ali Chief Executive Officer | 4,392 | $34.95 | $153,516 | 506,253 (Indirect Direct) | View |
| 2021-03-10 Sale | 2021-03-12 8:00 pm | Zymeworks Inc. | ZYME | HAUSMAN DIANA Chief Medical Officer | 1,048 | $34.95 | $36,631 | 69,252 (Indirect Direct) | View |
| 2021-03-10 Sale | 2021-03-12 8:00 pm | Zymeworks Inc. | ZYME | Klompas Neil A Chief Financial Officer | 1,425 | $34.95 | $49,809 | 73,046 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-11-10 Exercise | 2022-11-14 9:00 pm | N/A N/A | Zymeworks BC Inc. | ZYME | Josephson Neil Chief Medical Officer | 5,885 | $0 | 26,221 (Direct) | View |
| 2022-07-18 Option Award | 2022-07-19 9:05 pm | N/A 2032-07-17 | Zymeworks Inc. | ZYME | Moore Paul Andrew Chief Scientific Officer | 200,000 | $0 | 200,000 (Direct) | View |
| 2022-07-05 Option Award | 2022-07-05 9:00 pm | N/A N/A | Zymeworks Inc. | ZYME | Josephson Neil Chief Medical Officer | 1,525 | $4.51 | 11,039 (Direct) | View |
| 2022-07-05 Option Award | 2022-07-05 9:00 pm | N/A N/A | Zymeworks Inc. | ZYME | Klompas Neil A Chief Operating Officer | 1,525 | $4.51 | 15,501 (Direct) | View |
| 2022-03-10 Option Award | 2022-03-11 9:00 pm | N/A 2032-03-09 | Zymeworks Inc. | ZYME | Astle Christopher SVP & Chief Financial Officer | 125,000 | $0 | 125,000 (Direct) | View |
| 2022-03-10 Exercise | 2022-03-11 9:00 pm | N/A N/A | Zymeworks Inc. | ZYME | Klompas Neil A Chief Operating Officer | 5,208 | $0 | 221,893 (Direct) | View |
| 2022-03-10 Option Award | 2022-03-11 9:00 pm | N/A 2032-03-09 | Zymeworks Inc. | ZYME | Klompas Neil A Chief Operating Officer | 200,000 | $0 | 221,893 (Direct) | View |
| 2022-03-10 Exercise | 2022-03-11 9:00 pm | N/A N/A | Zymeworks Inc. | ZYME | Josephson Neil Chief Medical Officer | 2,395 | $0 | 13,578 (Direct) | View |
Ownership | 2022-03-04 9:20 pm | N/A N/A | Zymeworks Inc. | ZYME | Astle Christopher SVP & Chief Financial Officer | 0 | $0 | 21,020 (Direct) | View |
| 2022-01-15 Option Award | 2022-01-18 06:25 am | N/A 2032-01-14 | Zymeworks Inc. | ZYME | Galbraith Kenneth Chair, President & CEO | 500,000 | $0 | 500,000 (Direct) | View |
| 2022-01-07 Option Award | 2022-01-07 9:30 pm | N/A N/A | Zymeworks Inc. | ZYME | Josephson Neil Chief Medical Officer | 65 | $13.94 | 2,119 (Direct) | View |
| 2022-01-07 Option Award | 2022-01-07 9:30 pm | N/A N/A | Zymeworks Inc. | ZYME | Polverino Anthony J. Chief Scientific Officer | 74 | $13.94 | 36,407 (Direct) | View |
| 2022-01-07 Option Award | 2022-01-07 9:30 pm | N/A N/A | Zymeworks Inc. | ZYME | Klompas Neil A Chief Operating Officer & CFO | 277 | $13.94 | 11,747 (Direct) | View |
| 2021-11-10 Option Award | 2021-11-12 9:00 pm | N/A 2031-11-09 | Zymeworks Inc. | ZYME | Josephson Neil Chief Medical Officer | 123,600 | $0 | 123,600 (Direct) | View |
| 2021-08-31 Exercise | 2021-09-02 8:00 pm | N/A N/A | Zymeworks Inc. | ZYME | Polverino Anthony J. Chief Scientific Officer | 4,900 | $15 | 113,933 (Direct) | View |
| 2021-08-31 Exercise | 2021-09-02 8:00 pm | N/A 2028-12-11 | Zymeworks Inc. | ZYME | Polverino Anthony J. Chief Scientific Officer | 4,900 | $0 | 113,933 (Direct) | View |
| 2021-07-15 Exercise | 2021-07-16 9:30 pm | 2013-01-01 2022-01-01 | Zymeworks Inc. | ZYME | Tehrani Ali Chief Executive Officer | 44,991 | $0 | 357,027 (Direct) | View |
| 2021-07-16 Exercise | 2021-07-16 9:30 pm | N/A N/A | Zymeworks Inc. | ZYME | Tehrani Ali Chief Executive Officer | 41,191 | $4.2643 | 357,027 (Direct) | View |
| 2021-07-15 Exercise | 2021-07-16 9:30 pm | N/A N/A | Zymeworks Inc. | ZYME | Tehrani Ali Chief Executive Officer | 3,800 | $4.2713 | 357,027 (Direct) | View |
| 2021-07-12 Exercise | 2021-07-13 8:00 pm | N/A N/A | Zymeworks Inc. | ZYME | Tehrani Ali Chief Executive Officer | 12,669 | $4.3062 | 360,827 (Direct) | View |
| 2021-07-12 Exercise | 2021-07-13 8:00 pm | 2013-01-01 2022-01-01 | Zymeworks Inc. | ZYME | Tehrani Ali Chief Executive Officer | 12,669 | $0 | 360,827 (Direct) | View |
| 2021-07-06 Option Award | 2021-07-08 8:05 pm | N/A N/A | Zymeworks Inc. | ZYME | O'Driscoll Kathryn Chief People Officer | 510 | $29.49 | 6,350 (Direct) | View |
| 2021-07-06 Option Award | 2021-07-08 8:00 pm | N/A N/A | Zymeworks Inc. | ZYME | Polverino Anthony J. Chief Scientific Officer | 454 | $29.49 | 31,433 (Direct) | View |
| 2021-07-06 Option Award | 2021-07-08 8:00 pm | N/A N/A | Zymeworks Inc. | ZYME | Klompas Neil A Chief Financial Officer | 299 | $29.49 | 11,470 (Direct) | View |
| 2021-07-06 Option Award | 2021-07-08 8:00 pm | N/A N/A | Zymeworks Inc. | ZYME | Priour James Chief Commercial Officer | 510 | $29.49 | 2,513 (Direct) | View |
| 2021-07-06 Option Award | 2021-07-08 8:00 pm | N/A N/A | Zymeworks Inc. | ZYME | Josephson Neil Interim Chief Medical Officer | 461 | $29.49 | 2,054 (Direct) | View |
Ownership | 2021-05-25 9:00 pm | N/A N/A | Zymeworks Inc. | ZYME | Josephson Neil Interim Chief Medical Officer | 0 | $0 | 146,177 (Direct) | View |
| 2021-05-06 Option Award | 2021-05-07 8:45 pm | N/A 2031-05-05 | Zymeworks Inc. | ZYME | Neu Kelvin Director | 9,000 | $0 | 9,000 (Direct) | View |
| 2021-05-06 Option Award | 2021-05-07 8:45 pm | N/A 2031-05-05 | Zymeworks Inc. | ZYME | Hillan Kenneth J. Director | 9,000 | $0 | 9,000 (Direct) | View |
| 2021-05-06 Option Award | 2021-05-07 8:45 pm | N/A 2031-05-05 | Zymeworks Inc. | ZYME | Mahony Susan Director | 9,000 | $0 | 9,000 (Direct) | View |
| 2021-05-06 Option Award | 2021-05-07 8:45 pm | N/A 2031-05-05 | Zymeworks Inc. | ZYME | Sacks Natalie Director | 9,000 | $0 | 9,000 (Direct) | View |
| 2021-05-06 Option Award | 2021-05-07 8:45 pm | N/A 2031-05-05 | Zymeworks Inc. | ZYME | Cox Troy Director | 9,000 | $0 | 9,000 (Direct) | View |
| 2021-05-06 Option Award | 2021-05-07 8:45 pm | N/A 2031-05-05 | Zymeworks Inc. | ZYME | RENTON HOLLINGS Director | 9,000 | $0 | 9,000 (Direct) | View |
| 2021-05-06 Option Award | 2021-05-07 8:45 pm | N/A 2031-05-05 | Zymeworks Inc. | ZYME | Zoth Lota S. Director | 9,000 | $0 | 9,000 (Direct) | View |
| 2021-04-13 Exercise | 2021-04-13 9:30 pm | N/A N/A | Zymeworks Inc. | ZYME | Priour James Chief Commercial Officer | 2,266 | $0 | 6,537 (Direct) | View |
| 2021-03-15 Exercise | 2021-03-17 8:00 pm | N/A 2029-11-07 | Zymeworks Inc. | ZYME | O'Driscoll Kathryn Chief People Officer | 837 | $0 | 100,000 (Direct) | View |
| 2021-03-15 Exercise | 2021-03-17 8:00 pm | N/A N/A | Zymeworks Inc. | ZYME | O'Driscoll Kathryn Chief People Officer | 837 | $34.24 | 100,000 (Direct) | View |
| 2021-03-10 Exercise | 2021-03-12 8:00 pm | N/A N/A | Zymeworks Inc. | ZYME | O'Driscoll Kathryn Chief People Officer | 1,354 | $0 | 43,498 (Direct) | View |
| 2021-03-10 Option Award | 2021-03-12 8:00 pm | N/A 2031-03-09 | Zymeworks Inc. | ZYME | O'Driscoll Kathryn Chief People Officer | 35,000 | $0 | 43,498 (Direct) | View |
| 2021-03-10 Option Award | 2021-03-12 8:00 pm | N/A 2031-03-09 | Zymeworks Inc. | ZYME | Priour James Chief Commercial Officer | 43,750 | $0 | 43,750 (Direct) | View |
| 2021-03-10 Exercise | 2021-03-12 8:00 pm | N/A N/A | Zymeworks Inc. | ZYME | Polverino Anthony J. Chief Scientific Officer | 2,500 | $0 | 92,854 (Direct) | View |
| 2021-03-10 Option Award | 2021-03-12 8:00 pm | N/A 2031-03-09 | Zymeworks Inc. | ZYME | Polverino Anthony J. Chief Scientific Officer | 56,875 | $0 | 92,854 (Direct) | View |
| 2021-03-10 Exercise | 2021-03-12 8:00 pm | N/A N/A | Zymeworks Inc. | ZYME | Tehrani Ali Chief Executive Officer | 7,708 | $0 | 506,253 (Direct) | View |
| 2021-03-10 Option Award | 2021-03-12 8:00 pm | N/A 2031-03-09 | Zymeworks Inc. | ZYME | Tehrani Ali Chief Executive Officer | 175,000 | $0 | 506,253 (Direct) | View |
| 2021-03-10 Exercise | 2021-03-12 8:00 pm | N/A N/A | Zymeworks Inc. | ZYME | HAUSMAN DIANA Chief Medical Officer | 2,500 | $0 | 69,252 (Direct) | View |
| 2021-03-10 Option Award | 2021-03-12 8:00 pm | N/A 2031-03-09 | Zymeworks Inc. | ZYME | HAUSMAN DIANA Chief Medical Officer | 56,875 | $0 | 69,252 (Direct) | View |
| 2021-03-10 Exercise | 2021-03-12 8:00 pm | N/A N/A | Zymeworks Inc. | ZYME | Klompas Neil A Chief Financial Officer | 2,500 | $0 | 73,046 (Direct) | View |
| 2021-03-10 Option Award | 2021-03-12 8:00 pm | N/A 2031-03-09 | Zymeworks Inc. | ZYME | Klompas Neil A Chief Financial Officer | 56,875 | $0 | 73,046 (Direct) | View |